Diabetes linked to worse long COVID outcomes

· Medical Xpress

by Maria Fernanda Ziegler, FAPESP

edited by Gaby Clark, reviewed by Robert Egan

Gaby Clark

Scientific Editor

Meet our editorial team
Behind our editorial process

Robert Egan

Senior Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

The GIST Add as preferred source


The combination of altered metabolism due to diabetes and prolonged hospitalization creates a cycle of muscle mass loss and vulnerability that hinders a return to daily independence, says the last author of the study. Credit: Stéf -b/Pexels

People with diabetes who have had COVID-19 tend to recover more slowly, experience more long COVID complications, have a poorer quality of life, and require closer and more prolonged monitoring by medical teams. This was demonstrated in a study by the University of São Paulo, which involved 870 individuals followed for up to seven months after hospitalization. The study is published in the journal Scientific Reports.

"Diabetes isn't only a risk factor for the acute phase of COVID-19. It's also been shown to prolong recovery time and impair quality of life in the long term. The study makes it clear that a health care framework is needed for this population with diabetes who have been infected with the COVID-19 virus to prevent these survivors from becoming trapped in a cycle of readmissions," says Maria Elizabeth Rossi da Silva, one of the authors of the study. She is the head of the Diabetes Unit at Hospital das Clínicas (HC), a hospital complex administered by the University of São Paulo Medical School (FM-USP) in Brazil.

Slower recovery after discharge

The study found that people with diabetes took longer to recover from the virus and were at a higher risk of cardiovascular complications, such as heart attacks and angina, than those without diabetes. Seven months after discharge, the diabetic group showed elevated frailty levels, a higher incidence of falls, and a poorer quality of life. They experienced mobility difficulties, an inability to perform daily activities, and lower performance in physical and cognitive domains.

The study compared 320 patients with diabetes mellitus and 550 patients without the disease. It is part of a larger study that recruited more than 3,000 individuals admitted to HC between March and September 2020. This period corresponded to the first phase of the pandemic in Brazil, when vaccines were not yet available.

Approximately seven months after being discharged from the hospital, the participants underwent a comprehensive in-person evaluation, which included a physical examination and laboratory tests.

According to the results of the study, 94.3% of patients without diabetes reported full recovery, compared with 89.8% of patients with diabetes. "It's a considerable difference," Silva says.

How diabetes amplifies the damage

Silva explained that the cardiovascular system of people with diabetes comes under significant stress because of the virus. "The systemic inflammation caused by diabetes compounds the direct toxicity of the virus, creating a scenario in which the heart becomes one of the main targets for serious complications. And the risk increases with the number of comorbidities the patient has," she said.

The repercussions of this cascade effect are far-reaching. Among patients with diabetes, the virus severely compromised mobility. Twenty-one percent of these patients reported falls after discharge, nearly double the rate observed in patients without diabetes (11.1%).

"This combination of altered metabolism and prolonged hospital stay—which was longer among those with diabetes [16 days versus 13]—creates a cycle of muscle mass loss and vulnerability that hinders a return to daily autonomy," she tells Agência FAPESP.

For Silva, understanding these metabolic peculiarities and the socioeconomic challenges of diabetes is essential in clinical care. "The chronic inflammatory state associated with diabetes and obesity, combined with the accelerated progression of cardiac and functional damage, makes this group more susceptible to serious complications. Furthermore, the virus can directly affect pancreatic cells or trigger insulin resistance, worsening the condition," she explained.

She also emphasized that social inequalities influence disease outcomes. These inequalities include limited access to medical care, stress, unhealthy diets and lack of time for physical exercise. "Health policies must consider these factors, offering specific follow-up care for patients with diabetes in the post-COVID period," she said.

New diagnoses require caution

Another significant finding was that 7.3% of participants without diabetes developed the disease after a COVID-19 infection. However, Silva believes that while the direct role of the virus in destroying pancreatic cells cannot be ruled out, it is more likely that the infection revealed pre-existing cases or that the severe inflammatory response triggered the disease in people who were already predisposed.

"We must interpret this information with caution because, although the infection may catalyze the onset of diabetes, the pandemic itself and social isolation may also have influenced factors such as stress, poor diet, physical inactivity and obesity, all of which can trigger diabetes," she said.

The study of patients hospitalized at HC during the first phase of the pandemic is ongoing, and the researchers are analyzing data collected three years after infection. "It's important to understand how COVID-19 impacts diabetes over time," she said.

Publication details

Chin Jia Lin et al, Post-COVID-19 diabetes outcomes, Scientific Reports (2026). DOI: 10.1038/s41598-026-42284-7

Journal information: Scientific Reports

Key medical concepts

DiabetesPost-Acute COVID-19 SyndromeCardiovascular ComplicationMyocardial infarctionInsulin Resistance

Clinical categories

EndocrinologyCommon illnesses & PreventionInfectious diseases Provided by FAPESP Who's behind this story?

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Diabetes linked to worse long COVID outcomes (2026, June 29) retrieved 29 June 2026 from https://medicalxpress.com/news/2026-06-diabetes-linked-worse-covid-outcomes.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.